PT1490049E - Citalopram para o tratamento da pre3ssao sanguinia elevada. - Google Patents

Citalopram para o tratamento da pre3ssao sanguinia elevada.

Info

Publication number
PT1490049E
PT1490049E PT03743933T PT03743933T PT1490049E PT 1490049 E PT1490049 E PT 1490049E PT 03743933 T PT03743933 T PT 03743933T PT 03743933 T PT03743933 T PT 03743933T PT 1490049 E PT1490049 E PT 1490049E
Authority
PT
Portugal
Prior art keywords
citalopram
prevention
treatment
sanguinia
blood pressure
Prior art date
Application number
PT03743933T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of PT1490049E publication Critical patent/PT1490049E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Dental Preparations (AREA)
PT03743933T 2002-03-14 2003-03-13 Citalopram para o tratamento da pre3ssao sanguinia elevada. PT1490049E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0200980A HU0200980D0 (enExample) 2002-03-14 2002-03-14

Publications (1)

Publication Number Publication Date
PT1490049E true PT1490049E (pt) 2006-08-31

Family

ID=89980266

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03743933T PT1490049E (pt) 2002-03-14 2003-03-13 Citalopram para o tratamento da pre3ssao sanguinia elevada.

Country Status (34)

Country Link
US (1) US7141604B2 (enExample)
EP (1) EP1490049B1 (enExample)
JP (1) JP2005519945A (enExample)
KR (1) KR100718368B1 (enExample)
CN (1) CN1259912C (enExample)
AT (1) ATE324887T1 (enExample)
AU (1) AU2003211195B2 (enExample)
BG (1) BG108904A (enExample)
BR (1) BR0303384A (enExample)
CA (1) CA2459834A1 (enExample)
CY (1) CY1106129T1 (enExample)
CZ (1) CZ2004661A3 (enExample)
DE (1) DE60305018T2 (enExample)
DK (1) DK1490049T3 (enExample)
EA (1) EA008350B1 (enExample)
EE (1) EE200400069A (enExample)
ES (2) ES2238939B2 (enExample)
HR (1) HRP20040165B1 (enExample)
HU (1) HU0200980D0 (enExample)
IL (2) IL160486A0 (enExample)
IS (1) IS2392B (enExample)
LT (1) LT5255B (enExample)
LV (1) LV13281B (enExample)
MX (1) MXPA04008919A (enExample)
NO (1) NO20034998D0 (enExample)
PL (1) PL368902A1 (enExample)
PT (1) PT1490049E (enExample)
SI (1) SI1490049T1 (enExample)
SK (1) SK2222004A3 (enExample)
TR (1) TR200401036T1 (enExample)
UA (1) UA77506C2 (enExample)
WO (1) WO2003075914A1 (enExample)
YU (1) YU91203A (enExample)
ZA (1) ZA200408056B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06004029A (es) * 2003-10-10 2006-06-28 Solvay Pharm Gmbh Composicion farmaceutica que comprende un agonista del receptor de imidazolina selectivo i1 y un bloqueante del receptor de angiotensina ii.
DE102004002638A1 (de) * 2004-01-19 2005-08-18 Merck Patent Gmbh Kombinationen von Serotonin-Wiederaufnahme-Hemmern und Imidazolin-I2-Agonisten
EP2008653A1 (de) * 2007-06-28 2008-12-31 Charité-Universitätsmedizin Berlin Serotonerge Verbindungen zur Behandlung neuronaler Krankheiten

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552012A (en) 1975-12-16 1979-09-05 Du Pont Canada Process for the treatment of comminuted oats
JP3526581B2 (ja) * 1997-07-08 2004-05-17 ハー・ルンドベック・アクティーゼルスカブ シタロプラムの製造方法
CN1286687A (zh) * 1997-11-11 2001-03-07 H·隆德贝克有限公司 制备西酞普兰的方法
US6333357B1 (en) * 1999-11-05 2001-12-25 Be Able, Llc Behavior chemotherapy

Also Published As

Publication number Publication date
US7141604B2 (en) 2006-11-28
MXPA04008919A (es) 2004-11-26
IL160486A (en) 2008-06-05
ES2238939A1 (es) 2005-09-01
AU2003211195A2 (en) 2003-09-22
LT2004049A (en) 2005-03-25
DE60305018D1 (de) 2006-06-08
HRP20040165A2 (en) 2004-10-31
LV13281B (en) 2005-09-20
UA77506C2 (en) 2006-12-15
DE60305018T2 (de) 2006-11-30
EA200401147A1 (ru) 2005-02-24
HU0200980D0 (enExample) 2002-05-29
ATE324887T1 (de) 2006-06-15
BG108904A (en) 2006-04-28
ZA200408056B (en) 2005-10-10
WO2003075914A1 (en) 2003-09-18
JP2005519945A (ja) 2005-07-07
DK1490049T3 (da) 2006-08-21
HK1075390A1 (en) 2005-12-16
CY1106129T1 (el) 2011-06-08
LT5255B (lt) 2005-08-25
SI1490049T1 (sl) 2006-10-31
US20050065209A1 (en) 2005-03-24
HRP20040165B1 (hr) 2007-08-31
IS2392B (is) 2008-08-15
EP1490049A1 (en) 2004-12-29
ES2263009T3 (es) 2006-12-01
EA008350B1 (ru) 2007-04-27
IL160486A0 (en) 2004-07-25
CN1259912C (zh) 2006-06-21
EE200400069A (et) 2004-08-16
PL368902A1 (en) 2005-04-04
SK2222004A3 (en) 2004-08-03
CA2459834A1 (en) 2003-09-18
YU91203A (sh) 2006-08-17
TR200401036T1 (tr) 2005-10-21
CN1568183A (zh) 2005-01-19
KR20040090949A (ko) 2004-10-27
AU2003211195B2 (en) 2007-10-18
EP1490049B1 (en) 2006-05-03
IS7418A (is) 2004-08-20
BR0303384A (pt) 2004-03-30
AU2003211195A1 (en) 2003-09-22
CZ2004661A3 (cs) 2004-10-13
ES2238939B2 (es) 2006-04-16
NO20034998D0 (no) 2003-11-10
KR100718368B1 (ko) 2007-05-14

Similar Documents

Publication Publication Date Title
WO2003053368A3 (en) Chalcone derivatives and their use to treat diseases
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
MXPA05004247A (es) Cromonas y derivados de cromona y usos de los mismos.
WO2004030611A3 (en) Non-nucleoside reverse transcriptase inhibitors
BR0210139A (pt) Composições farmacêuticas
PL374443A1 (en) Novel pyrimidineamide derivatives and the use thereof
SE0101932D0 (sv) Pharmaceutical combinations
WO2004073615A8 (en) Deazaflavin compounds and methods of use thereof
PT1150704E (pt) Melagatran para o tratamento da inflamacao
BG108452A (en) Tablet comprising cetirizine and pseudoephedrine
ATE286894T1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
MXPA04001847A (es) Uso de sistemas de indan-1-ol polisbstituidos para producir drogas utilizadas en la profilaxis o tratamiento de la obesidad.
MXPA04001912A (es) Aminobenzofenonas novedosas.
MY139613A (en) Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
IS2392B (is) Sítalópram til að meðhöndla hækkaðan blóðþrýsting
NO20054346L (no) Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander
EP1411956B8 (en) Use of oversulfated polysaccharides as inhibitors of hiv
EA200500865A1 (ru) Синергетическая комбинация, включающая рофлумиласт и r,r-формотерол
ITRM20010293A1 (it) Uso della acetil-l-carnetina per la preparazione di un medicamento per la prevenzione del dolore.
WO2004073627A3 (en) Novel therapeutic method and compositions for topical administration
HRP20050497B1 (hr) Uporaba levocetirizina za liječenje stalnog alergijskog rinitisa
WO2005035746A3 (en) Medical use of tbk-1 or of inhibitors thereof
PL367628A1 (en) Use of an alkanoyl l-carnitine for the preparation of a medication to treat anhedonia
SE0202287D0 (sv) New compounds